MKI67 and cancer: IHC analysis of the excised tumors derived from the OTS186935-treated mice demonstrated a significantly lower percentage of Ki-67 positive cells compared to the control mice (P = 0.003) (Figure 4G), indicating suppression of A549 cancer cell proliferation.